Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC

Richard Beasley · The Lancet · 1998 · 3.4K citations

Life Sciences, Immunology, Allergy +11

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee.

PubMed · 1998 · 1.9K citations

Life Sciences, Child Health, Pediatrics +13

Epidemiology of Physician-Diagnosed Allergic Rhinitis in Childhood

Anne L. Wright, Catharine J. Holberg, Marilyn Halonen et al. · PEDIATRICS · 1994 · 441 citations

Life Sciences, Child Health, Pediatrics +15

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

Van Cauwenberge, Juniper · Clinical & Experimental Allergy · 2000 · 171 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis☆☆☆

Peter Howarth, Martin Stern, Larry D. Roi et al. · Journal of Allergy and Clinical Immunology · 1999 · 164 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +9